Daly buys at BAT

A round-up of the biggest director deals today so far.

British American Tobacco's chief operating officer John Daly has invested nearly £511,000 in shares in the tobacco company.

He has bought 21,200 shares at 2408.57p each and that takes his beneficial stake to 52,417 shares.

Daly joined BAT as a result of its merger with Rothmans in 1999. He was appointed as chief operating officer of the group in September at the same time that Nicandro Durante took on the role of chief executive designate. Durante takes over as chief executive next February. Daly was previously regional director for Asia Pacific.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

In July, BAT said that it expects another year of good growth in both earnings and dividends. Pre-tax profit rose to £2,279m in the six months to 30 June, up from £2,123m in the first half of 2009.

The tobacco firm increased its interim dividend from 27.9p a share to 33.2p a share.

Top Director Buys

British American Tobacco (BATS) Director name: Mr John DalyAmount purchased: 21,200 @ 2,408.57p Value: £510,617

PSG Solutions (PGS) Director name: Mr Bernard Cavan ConnorAmount purchased: 300,000 @ 24.00p Value: £72,000

GlaxoSmithKline (GSK) Director name: Dr Dr Dan PodolskyAmount purchased: 2,078 @ 1,265.19p Value: £26,291

GlaxoSmithKline (GSK) Director name: Sir Christopher GentAmount purchased: 2,685 @ 1,257.00p Value: £33,750

Ascent Resources (AST) Director name: Mr Jeremy EngAmount purchased: 699,815 @ 4.38p Value: £30,652

GlaxoSmithKline (GSK) Director name: Mr Lawrence CulpAmount purchased: 1,539 @ 1,265.19p Value: £19,471

Cyan (CYAN) Director name: Dr John ReadAmount purchased: 3,088,221 @ 0.90p Value: £27,794

Cyan (CYAN) Director name: Mr Simon Smith Amount purchased: 2,777,778 @ 0.90p Value: £25,000

GlaxoSmithKline (GSK) Director name: Sir Sir Crispin H L DavisAmount purchased: 1,889 @ 1,257.00p Value: £23,745

Unilever (ULVR) Director name: Ms Ann M FudgeAmount purchased: 700 @ 1,849.80p Value: £12,949

Top Director Sells

Centamin Egypt (CEY) Director name: Mr Stuart BottomleyAmount sold: 200,000 @ 179.78p Value: £359,560

Centamin Egypt (CEY) Director name: Mr Stuart BottomleyAmount sold: 200,000 @ 178.26p Value: £356,520

BrainJuicer Group (BJU) Director name: Mr James GeddesAmount sold: 125,000 @ 200.00p Value: £250,000

Centamin Egypt (CEY) Director name: Mr Stuart BottomleyAmount sold: 100,000 @ 177.91p Value: £177,910

Red Rock Resources (RRR) Director name: Mr Andrew Ronald McMillan BellAmount sold: 1,000,000 @ 6.09p Value: £60,900